Cancer

211 Items

All Items

miR-149-3p targeting TMPRSS4 regulates the sensitivity to cisplatin to inhibit the progression of lung cancer

Beibei Qin, Dongfang Tang, Mingzhi Zhang

165–176
F13B regulates angiogenesis and tumor progression in hepatocellular carcinoma via the HIF-1α/VEGF pathway

Dong Jiang, Zhi Qi, Zhi-ying Xu, Yi-ran Li

189–209
Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index

Nulifer Kilic Durankus, Efsun Somay, Sibel Bascil, Sukran Senyurek, Duriye Ozturk, Ugur Selek, Erkan Topkan

240–248
The relationship between tumor budding and survival of patients with breast cancer: A meta-analysis

Hongjie Xu, Dajun Wei

1546–1558
Bioinformatics analysis and experimental validation of C6orf120 as a potential prognostic marker and therapeutic target for liver hepatocellular carcinoma

Yingying Lin, Xin Wang, Yanyan Li, Xinyu Cui, Na Zhu, Xin Li
Co-expression of miRNA players in advanced laryngeal carcinoma – Insights into the roles of miR-93-5p, miR-145-5p, and miR-210-3p

Silva Kyurkchiyan, Veronika Petkova, Gergana Stancheva, Iglika Stancheva, Stoyan Dimitrov, Venera Dobriyanova, Diana Popova, Radka Kaneva, Todor Miroslavov Popov
VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating UBR5 mRNA and m6A levels

Chunyu Zhu, Yameng Cheng, Yao Yu, Yanning Zhang, Guiyun Ren

1244–1257
Clinical diagnostic value of contrast-enhanced ultrasound combined with microflow imaging in benign and malignant renal tumors: A retrospective cohort study

Xiufeng Kuang, Huiyang Wang, Weilu Chai, Huafang Yuan, Ting He, Mengya Shi, Tianan Jiang

1370–1379
SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway

Hang Jiang, Zhiqian Xue, Liping Zhao, Boyuan Wang, Chenfei Wang, Haihan Song, Jianjun Sun

1231–1243
Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapy

Semir Vranic, Zoran Gatalica

673–675
Cuproptosis-related gene LIPT1 as a prognostic indicator in non-small cell lung cancer: Functional involvement and regulation of ATOX1 expression

Ruiyun Deng, Lili Zhu, Jun Jiang, Jing Chen, Hua Li

647–658
Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells

Huimin Li, Xiyu Tang, Zhiwei Sun, Zhongyuan Qu, Xiang Zou

560–574
The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

Zhen Pan, Ye Wang, Shoufeng Li, Huajun Cai, Guoxian Guan

612–624
Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

Zhenchi Li, Zhibin Xu, Jiangping Wang, Mei Wang

633–646
Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern

Zhaoyuan Xue, Yiliyaer Nuerrula, Yilidana Sitiwaerdi, Mayinur Eli

545–559
Progress of lymphocyte activation gene 3 and programmed cell death protein 1 antibodies for cancer treatment: A review

Yu-Quan Li, Xue-Mei Chen, Gui-Fei Si, Xue-Min Yuan

764-774
Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab

Hasan Cagri Yildirim, Hicran Anik, Deniz Ates Ozdemir, Rashad Ismayilov, Arif Akyildiz, Kerim Cayiroz, Fahri Ceyhan, Oguzalp Kavruk, Deniz Can Guven, Ozturk Ates, Alp Usubutun, Zafer Arik

998-1003
GATA2 mutant variant allele frequency may reflect prognosis in Chinese adult patients with de novo cytogenetically normal acute myeloid leukemia

Huanying Ren, Minglin Hong, Jingyi Feng, Zhuanghui Hao, Xian Chen, Fengting Liang, Wei Wei, Xuelan Liang, Hongwei Wang, Xiuhua Chen

982-989
Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer

Cui Tang, Aili Wang, YanLin Zhao, WenYing Mou, Jun Jiang, Jie Kuang, Bin Sun, Erjiang Tang

968-981
CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer

Weidan Fang, Dewen Wan, Yi Yu, Ling Zhang

101–124

1-20 of 211 Next